Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, November 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 81 articles:
HTML format


 

Single Articles

  1. PEREZ-BEREZO T, Pujo J, Martin P, Le Faouder P, et al
    Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917.
    Nat Commun. 2017;8:1314.
    Abstract    

    Abstract available

  2. JOHNSEN PH, Hilpusch F, Cavanagh JP, Leikanger IS, et al
    Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
    Lancet Gastroenterol Hepatol. 2017 Oct 31. pii: S2468-1253(17)30338.
    Abstract    

    Abstract available

  3. ASANO T, Takenaga M
    Adenosine A2B Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  4. VICARI E, Salemi M, Sidoti G, Malaguarnera M, et al
    Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  5. ENCK P, Azpiroz F, Boeckxstaens G, Elsenbruch S, et al
    Functional dyspepsia.
    Nat Rev Dis Primers. 2017;3:17081.
    Abstract    

    Abstract available

  6. PATIMAH AW, Lee YY, Dariah MY
    Frequency patterns of core constipation symptoms among the Asian adults: a systematic review.
    BMC Gastroenterol. 2017;17:115.
    Abstract    

    Abstract available

  7. CRAIG O
    New therapies in Irritable Bowel Syndrome: what works and when.
    Curr Opin Gastroenterol. 2017 Nov 1. doi: 10.1097/MOG.0000000000000411.
    Abstract    

    Abstract available

  8. SAMPOGNARO P, Vo KT, Richie M, Blanc PD, et al
    Bismuth Subgallate Toxicity in the Age of Online Supplement Use.
    Neurologist. 2017;22:237-240.
    Abstract    

    Abstract available

  9. TUCK CJ, Vanner SJ
    Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions.
    Neurogastroenterol Motil. 2017 Nov 2. doi: 10.1111/nmo.13238.
    Abstract    

    Abstract available

  10. BARSHOP K, Staller K
    Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy.
    Ther Adv Chronic Dis. 2017;8:153-160.
    Abstract    

    Abstract available

  11. WOHLFARTH C, Schmitteckert S, Hartle JD, Houghton LA, et al
    miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome.
    Sci Rep. 2017;7:14680.
    Abstract    

    Abstract available

  12. SESSENWEIN JL, Baker CC, Pradhananga S, Maitland ME, et al
    Protease-mediated suppression of DRG neuron excitability by commensal bacteria.
    J Neurosci. 2017 Oct 31. pii: 1672-17. doi: 10.1523/JNEUROSCI.1672-17.2017.
    Abstract    

    Abstract available

  13. ZWEIG A, Pohl D

    Praxis (Bern 1994). 2017;106:1229-1235.
    Abstract    



  14. RAHMAN MM, Mahadeva S, Ghoshal UC
    Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.
    World J Gastroenterol. 2017;23:6788-6801.
    Abstract    

    Abstract available

  15. SINAGRA E, Morreale GC, Mohammadian G, Fusco G, et al
    New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.
    World J Gastroenterol. 2017;23:6593-6627.
    Abstract    

    Abstract available

  16. FAN K, Talley NJ
    Functional Dyspepsia and Duodenal Eosinophilia: A New Disease Model.
    J Dig Dis. 2017 Oct 30. doi: 10.1111/1751-2980.12556.
    Abstract    

    Abstract available

  17. RUFFLE JK, Coen SJ, Giampietro V, Williams SCR, et al
    Morphology of subcortical brain nuclei is associated with autonomic function in healthy humans.
    Hum Brain Mapp. 2017 Oct 28. doi: 10.1002/hbm.23850.
    Abstract    

    Abstract available

  18. ZHOU Q, Wesselmann U, Walker L, Lee L, et al
    AAPT Diagnostic Criteria for Chronic Abdominal, Pelvic, and Urogenital Pain: Irritable Bowel Syndrome.
    J Pain. 2017 Oct 24. pii: S1526-5900(17)30737.
    Abstract    

    Abstract available

  19. RIZZO AG, Orlando A, Gallo E, Bisanti A, et al
    Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?
    J Clin Virol. 2017;97:1-3.
    Abstract    

    Abstract available

  20. CAMILLERI M, Ford AC
    Pharmacotherapy for Irritable Bowel Syndrome.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  21. VAN BEURDEN YH, Terveer EM, Keller JJ, Kuijper EJ, et al
    [Faecal microbiota transplantation: indications in perspective].
    Ned Tijdschr Geneeskd. 2017;161:D1623.
    Abstract    

    Abstract available

  22. LACY BE, Patel NK
    Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  23. TAN LH, Li KG, Wu YY, Lan Y, et al
    [Effect of Electroacupuncture at "Yintang" (GV 29) and "Tianshu" (ST 25) on the Ethology and the Expression of TRPV 1 Receptor in Colon of Irritable Bowel Syndrome Rats].
    Zhen Ci Yan Jiu. 2017;42:136-40.
    Abstract    

    Abstract available

  24. SHI H, Zhu X, Cui Y, Qin Y, et al
    Analgesic activity of cynaropicrinon on post-inflammatory irritable bowel syndrome visceral hypersensitivity in a rat model.
    Exp Ther Med. 2017;14:4476-4482.
    Abstract    

    Abstract available

  25. MANDL T, Marsal J, Olsson P, Ohlsson B, et al
    Severe intestinal dysbiosis is prevalent in primary Sjogren's syndrome and is associated with systemic disease activity.
    Arthritis Res Ther. 2017;19:237.
    Abstract    

    Abstract available

  26. LI P, Wuthrick E, Rappaport JA, Kraft C, et al
    GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
    Cancer Res. 2017;77:5095-5106.
    Abstract    

    Abstract available

  27. IQBAL M, Ezzeldin E, Al-Rashood KA, Al-Shdefat R, et al
    High throughput mu-SPE based elution coupled with UPLC-MS/MS for determination of eluxadoline in plasma sample: Application in pharmacokinetic characterization of PLGA nanoparticle formulations in rats.
    J Pharm Biomed Anal. 2017;149:172-178.
    Abstract    

    Abstract available

  28. WAEHRENS R, Zoller B, Sundquist J, Sundquist K, et al
    A Swedish national adoption study of risk of irritable bowel syndrome (IBS).
    BMJ Open Gastroenterol. 2017;4:e000156.
    Abstract    

    Abstract available

  29. LAATIKAINEN R, Koskenpato J, Hongisto SM, Loponen J, et al
    Pilot Study: Comparison of Sourdough Wheat Bread and Yeast-Fermented Wheat Bread in Individuals with Wheat Sensitivity and Irritable Bowel Syndrome.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  30. ZIA J, Chung CF, Xu K, Dong Y, et al
    Inter-Rater Reliability of Provider Interpretations of Irritable Bowel Syndrome Food and Symptom Journals.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  31. OZAKI RKF, Speridiao PDGL, Soares ACF, Morais MB, et al
    Intestinal fructose malabsorption is associated with increased lactulose fermentation in the intestinal lumen.
    J Pediatr (Rio J). 2017 Oct 28. pii: S0021-7557(17)30001.
    Abstract    

    Abstract available

  32. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
    Eur J Pharmacol. 2017;818:228-234.
    Abstract    

    Abstract available

  33. VORK L, Keszthelyi D, Mujagic Z, Kruimel JW, et al
    Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 Nov 6. doi: 10.1111/nmo.13244.
    Abstract    

    Abstract available

  34. ARENDT-NIELSEN L, Morlion B, Perrot S, Dahan A, et al
    Assessment and manifestation of central sensitisation across different chronic pain conditions.
    Eur J Pain. 2017 Nov 5. doi: 10.1002/ejp.1140.
    Abstract    

    Abstract available

  35. LEI CC, Li L, Zhang H, Li J, et al
    [Effect of Electroacupuncture Stimulation of Sensitized Acupoints on Bowel Dysfunction in Rats with Diarrhea-predominant Irritable Bowel Syndrome].
    Zhen Ci Yan Jiu. 2017;42:413-7.
    Abstract    

    Abstract available

  36. YANG DY, Wang H, Li J, Wu S, et al
    [Effect of Electroacupuncture at "Zusanli" (ST 36) on Vimentin (A Kind of Cytoskeleton Protein Related to Smooth Muscle Contraction) in Rats with Diarrhea-predominant Irritable Bowel Syndrome].
    Zhen Ci Yan Jiu. 2017;42:402-6.
    Abstract    

    Abstract available

  37. SHERWIN LB, Ozoji OM, Boulineaux CM, Joseph PV, et al
    Gender and Weight Influence Quality of Life in Irritable Bowel Syndrome.
    J Clin Med. 2017;6.
    Abstract    

    Abstract available

  38. SCHATZ RA, Moshiree B
    Gastrointestinal and Hepatic Disease in Fibromyalgia.
    Rheum Dis Clin North Am. 2018;44:131-142.
    Abstract    

    Abstract available

  39. BURNSTOCK G, Jacobson KA, Christofi FL
    Purinergic drug targets for gastrointestinal disorders.
    Curr Opin Pharmacol. 2017;37:131-141.
    Abstract    

    Abstract available

  40. OMER A, Quigley EMM
    An update on prucalopride in the treatment of chronic constipation.
    Therap Adv Gastroenterol. 2017;10:877-887.
    Abstract    

    Abstract available

  41. GRUNDY L, Brierley SM
    Cross-organ sensitisation between the colon and bladder: To pee, or not to pee?
    Am J Physiol Gastrointest Liver Physiol. 2017 Nov 16:ajpgi.00272.2017.
    Abstract    

    Abstract available

  42. FUKUBA N, Ishihara S, Kawashima K, Mishima Y, et al
    Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission.
    Intest Res. 2017;15:543-545.
    Abstract    



  43. IGBINEDION SO, Ansari J, Vasikaran A, Gavins FN, et al
    Non-celiac gluten sensitivity: All wheat attack is not celiac.
    World J Gastroenterol. 2017;23:7201-7210.
    Abstract    

    Abstract available

  44. EL-BADRY AA, Abd El Wahab WM, Hamdy DA, Aboud A, et al
    Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.
    Parasitol Res. 2017 Nov 14. doi: 10.1007/s00436-017-5679.
    Abstract    

    Abstract available

  45. CAI YY, Li C, Yan ZX, Ma N, et al
    Effects of SCN9A gene modification on Na+ channel and the expression of nerve growth factor in a rat model of diarrheapredominant irritable bowel syndrome.
    Mol Med Rep. 2017 Nov 14. doi: 10.3892/mmr.2017.8061.
    Abstract    

    Abstract available

  46. KHAYYATZADEH SS, Vatanparast H, Avan A, Bagherniya M, et al
    Serum Transaminase Concentrations and the Presence of Irritable Bowel Syndrome Are Associated with Serum 25-Hydroxy Vitamin D Concentrations in Adolescent Girls Who Are Overweight and Obese.
    Ann Nutr Metab. 2017;71.
    Abstract    

    Abstract available

  47. SEITZ A, Bandiera SM
    Analysis and Measurement of Serotonin.
    Biomed Chromatogr. 2017 Nov 14. doi: 10.1002/bmc.4135.
    Abstract    

    Abstract available

  48. ACKER BW, Cash BD
    Medicinal Foods for Functional GI Disorders.
    Curr Gastroenterol Rep. 2017;19:62.
    Abstract    

    Abstract available

  49. DEGEORGE KC, Frye JW, Stein KM, Rollins LK, et al
    Celiac Disease and Gluten Sensitivity.
    Prim Care. 2017;44:693-707.
    Abstract    

    Abstract available

  50. DEFREES DN, Bailey J
    Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment.
    Prim Care. 2017;44:655-671.
    Abstract    

    Abstract available

  51. KULAK-BEJDA A, Bejda G, Waszkiewicz N
    Antidepressants for irritable bowel syndrome-A systematic review.
    Pharmacol Rep. 2017;69:1366-1379.
    Abstract    

    Abstract available

  52. LI N, Tian H
    [Current research progress and thinking of fecal microbiota transplantation for the treatment of gastrointestinal disorders].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:1104-1108.
    Abstract    

    Abstract available

  53. SCARPATO E, Kolacek S, Jojkic-Pavkov D, Konjik V, et al
    Prevalence of Functional Gastrointestinal Disorders in Children and Adolescents in the Mediterranean Region of Europe.
    Clin Gastroenterol Hepatol. 2017 Nov 9. pii: S1542-3565(17)31316.
    Abstract    

    Abstract available

  54. SCHUMANN D, Klose P, Lauche R, Dobos G, et al
    Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Nutrition. 2018;45:24-31.
    Abstract    

    Abstract available

  55. LONGSTRETH GF, Chen Q, Wong C, Yao JF, et al
    Increased Systemic Antibiotic Use And Clostridium difficile Infection Among Outpatients With Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2017 Nov 8. pii: S1542-3565(17)31315.
    Abstract    



  56. YU YR, Rodriguez JR
    Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
    Semin Pediatr Surg. 2017;26:349-355.
    Abstract    

    Abstract available

  57. MARTIN CR, Mayer EA
    Gut-Brain Axis and Behavior.
    Nestle Nutr Inst Workshop Ser. 2017;88:45-53.
    Abstract    

    Abstract available

  58. BAG S, Ghosh TS, Das B
    Complete Genome Sequence of Collinsella aerofaciens Isolated from the Gut of a Healthy Indian Subject.
    Genome Announc. 2017;5.
    Abstract    

    Abstract available

  59. STREGE PR, Mazzone A, Bernard CE, Neshatian L, et al
    Irritable bowel syndrome (IBS) patients have SCN5A channelopathies that lead to decreased NaV1.5 current and mechanosensitivity.
    Am J Physiol Gastrointest Liver Physiol. 2017 Nov 22:ajpgi.00016.2017.
    Abstract    

    Abstract available

  60. FABIAN E, Schiller D, Toplak H, Brunner-Krainz M, et al
    Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.
    Wien Klin Wochenschr. 2017 Nov 21. doi: 10.1007/s00508-017-1291.
    Abstract    



  61. BONAZ B, Sinniger V, Pellissier S
    The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract.
    Front Immunol. 2017;8:1452.
    Abstract    

    Abstract available

  62. XU S, Qin B, Shi A, Zhao J, et al
    Oxytocin inhibited stress induced visceral hypersensitivity, enteric glial cells activation, and release of proinflammatory cytokines in maternal separated rats.
    Eur J Pharmacol. 2017 Nov 18. pii: S0014-2999(17)30752.
    Abstract    

    Abstract available

  63. OH SH, Kang HY
    Identification of target risk groups for population-based Clostridium difficile infection prevention strategies using a population attributable risk approach.
    Int J Infect Dis. 2017 Nov 18. pii: S1201-9712(17)30303.
    Abstract    

    Abstract available

  64. CATASSI C, Alaedini A, Bojarski C, Bonaz B, et al
    The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  65. HERZLINGER M, Cerezo C
    Functional Abdominal Pain and Related Syndromes.
    Child Adolesc Psychiatr Clin N Am. 2018;27:15-26.
    Abstract    

    Abstract available

  66. XIONG L, Wang Y, Gong X, Chen M, et al
    Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: data from a tertiary center in southern China.
    J Health Popul Nutr. 2017;36:38.
    Abstract    

    Abstract available

  67. MANRIQUE VERGARA D, Gonzalez Sanchez ME
    [Short chain fatty acids (butyric acid) and intestinal diseases].
    Nutr Hosp. 2017;34.
    Abstract    

    Abstract available

  68. CHAO G, Wang Y, Zhang S, Yang W, et al
    MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats.
    Oncotarget. 2017;8:85828-85837.
    Abstract    

    Abstract available

  69. ESWARAN S, Farida JP, Green J, Miller JD, et al
    Nutrition in the management of gastrointestinal diseases and disorders: the evidence for the low FODMAP diet.
    Curr Opin Pharmacol. 2017;37:151-157.
    Abstract    

    Abstract available

  70. YISIREYILI M, Uchida Y, Yamamoto K, Nakayama T, et al
    Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via AT1a signaling and ACE2-dependent mechanism in mice.
    Brain Behav Immun. 2017 Nov 16. pii: S0889-1591(17)30511.
    Abstract    

    Abstract available

  71. GUCLU M, Agan AF
    Relationship of peripheral blood neutrophil to lymphocyte ratio and irritable bowel syndrome
    Turk J Med Sci. 2017;47:1067-1071.
    Abstract    

    Abstract available

  72. ABADI ATB
    Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required.
    World J Gastrointest Pharmacol Ther. 2017;8:208-209.
    Abstract    

    Abstract available

  73. JADALLAH KA, Nimri LF, Ghanem RA
    Protozoan parasites in irritable bowel syndrome: A case-control study.
    World J Gastrointest Pharmacol Ther. 2017;8:201-207.
    Abstract    

    Abstract available

  74. SCHUMANN D, Langhorst J, Dobos G, Cramer H, et al
    Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Oct 27. doi: 10.1111/apt.14400.
    Abstract    

    Abstract available

  75. MEARIN F
    Irritable Bowel Syndrome: Pain in Spain.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    Abstract    



  76. SKODJE GI, Sarna VK, Minelle IH, Rolfsen KL, et al
    Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-reported Non-celiac Gluten Sensitivity.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36302.
    Abstract    

    Abstract available

  77. ZAHEDI MJ, Behrouz V, Azimi M
    Low FODMAPs diet vs. general dietary advice improves clinical response in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled trial.
    J Gastroenterol Hepatol. 2017 Nov 20. doi: 10.1111/jgh.14051.
    Abstract    

    Abstract available

  78. WAEHRENS R, Li X, Sundquist J, Sundquist K, et al
    Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort.
    Scand J Gastroenterol. 2017 Nov 10:1-8. doi: 10.1080/00365521.2017.1398345.
    Abstract    

    Abstract available

  79. LARSEN T, Hausken T, Otteraaen Ystad S, Hovdenak N, et al
    Does the low FODMAP diet improve symptoms of radiation-induced enteropathy? A pilot study.
    Scand J Gastroenterol. 2017 Nov 7:1-8. doi: 10.1080/00365521.2017.1397186.
    Abstract    

    Abstract available

  80. ZINSMEISTER AR, Herrick LM, Saito Loftus YA, Schleck CD, et al
    Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study.
    Scand J Gastroenterol. 2017 Nov 6:1-10. doi: 10.1080/00365521.2017.1395908.
    Abstract    

    Abstract available

  81. KOMPEROD MJ, Sommer C, Mellin-Olsen T, Iversen PO, et al
    Persistent symptoms in patients with Crohn's disease in remission: An exploratory study on the role of diet.
    Scand J Gastroenterol. 2017 Nov 23:1-6. doi: 10.1080/00365521.2017.1397736.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;